Gujarat Kidney appoints Paresh Dhoti as Non-Executive Non-Independent Director
Gujarat Kidney and Super Speciality Ltd appointed Mr Paresh Dhoti as an Additional Non-Executive Non-Independent Director on July 9, 2026, due to a technical issue with his independent director registration. The company will consider him for the Independent Director role in a future board meeting.

*this image is generated using AI for illustrative purposes only.
Gujarat Kidney and Super Speciality Ltd appointed Mr Paresh Dhoti as an Additional Non-Executive Non-Independent Director on July 9, 2026. The appointment was necessitated by a technical glitch that prevented the completion of his registration as an Independent Director with the Indian Institute of Corporate Affairs (IICA). The company stated that the registration process has since been completed successfully, and the Board will consider appointing him as a Non-Executive Independent Director in a subsequent meeting.
The clarification was submitted to BSE Limited and National Stock Exchange of India Limited regarding the outcome of the Board Meeting held on July 9, 2026. The disclosure was made under Regulation 30(6) read with Para A (7) of Part-A of Schedule III of the SEBI Listing Regulations and SEBI Circular No. SEBI/HO/CFD/CFD PoD1/P/CIR/2023/123 dated July 13, 2023.
Mr Paresh Dhoti obtained a Bachelor of Dentistry in 2006 from Government Medical College, Ahmedabad. He has been practicing independently as a Dentist in Vadodara for the past 18 years. The company confirmed that Mr Dhoti is not related to any Director of the company.
Appointment Details
| Particulars | Description |
|---|---|
| Reason for change | Appointment as an Additional Non-Executive Non Independent Director |
| Date of appointment | 09.07.2026 |
| Brief profile | Bachelor of Dentistry (2006), Government Medical College, Ahmedabad; practicing independently in Vadodara for 18 years |
| Disclosure of relationships | Not related to any Director of the Company |
Historical Stock Returns for Gujarat Kidney and Super Speciality
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.71% | -0.45% | +0.75% | +29.03% | +22.63% | +22.63% |
What specific strategic value will Mr. Dhoti's medical background bring to the Board of a kidney care and super-specialty hospital company?
How will the Board structure evolve once Mr. Dhoti transitions from a Non-Independent to an Independent Director role?
Is the company anticipating any further governance or compliance changes following the resolution of the IICA registration issue?


































